Novartis, Lonza strengthen biosimilars push with MS, arthritis drug deals Medical Dialogues Bureau3 Sept 2019 9:30 AM ISTNovartis's Sandoz generics unit, among the biggest biosimilars makers, on Tuesday, agreed to license from Poland's Polpharma Biologics a version of...
Sanofi revival depends on outsider with nose for big drugs: Report Medical Dialogues Bureau3 Sept 2019 8:58 AM ISTDefining Sanofi's ambitions in the cutting-edge field of gene therapies and figuring out whether to hold on to consumer health brands are among other...
DOP junks Cipla plea to refix MRP of Tafmune–EM Farhat Nasim2 Sept 2019 4:34 PM ISTNew Delhi: Through a recent decision, the Department of Pharmaceuticals (DOP) has rejected the review application filed by Cipla Limited against...
Amgen challenges Alexion Pharma blood disorder treatment Soliris in US patent court Medical Dialogues Bureau2 Sept 2019 9:30 AM ISTThe IPR is seeking to invalidate new patents covering the composition of the main ingredient of Soliris, eculizumab, its formulation, and its use to...
AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business Farhat Nasim31 Aug 2019 2:35 PM ISTNew Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e...
GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore Medical Dialogues Bureau31 Aug 2019 12:54 PM ISTMumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
Alkem Labs gets 2 USFDA observations for Daman facility Medical Dialogues Bureau31 Aug 2019 12:32 PM ISTNew Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received two observations from the US health regulator for...
Mylan gets tentative USFDA nod for generic of Eli Lilly lung cancer drug Alimta Medical Dialogues Bureau31 Aug 2019 9:30 AM ISTAlimta is Lilly's third biggest-selling drug. The Indianapolis-based drugmaker reported second-quarter sales of $577.8 million for the medicine.U.S:...
Cracking Down on Spurious Drugs: Union Health Ministry directs States to create Intelligence Cells with CDSCO Medical Dialogues Bureau30 Aug 2019 2:57 PM ISTThese intelligence cells will work in coordination with the officers of state drug departments and the Central Drug Control Standard Organisation...
Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945 Medical Dialogues Bureau29 Aug 2019 4:10 PM ISTNew Delhi: The Drugs Technical Advisory Board (DTAB) has recently recommended for amendment of the Drugs and Cosmetics Rules, 1945 regarding...
Strides Pharma acquires manufacturing plant in Florida for Rs 3.59 crore Farhat Nasim27 Aug 2019 2:30 PM IST"Strides Pharma Inc has acquired the manufacturing facility under an asset purchase agreement with Micelle Biopharma Inc for a consideration of USD...
Lupin inks commercial pact with Creso Pharma for cannaQIX Medical Dialogues Bureau27 Aug 2019 10:00 AM ISTAs per the agreement, Creso has given Pharma Dynamics sole distribution rights of its products across South Africa, Namibia, Botswana, Zimbabwe,...
